BRCA1 and familial pancreatic carcinoma: Because of their crucial role in the DNA double-strand break repair process via homologous recombination (HR), BRCA1 and BRCA2 (BRCA1/2) are among the most tested genes in patients with breast, ovarian, prostate, or pancreatic cancer (Yamamoto and Hirasawa 2021).